Vitronectin receptor antagonist pharmaceuticals for use in combination therapy

Details for Australian Patent Application No. 2001270025 (hide)

Owner Bristol-Myers Squibb Pharma Company

Inventors Carpenter Jr., Alan P.; Barrett, John A; Rajopadhye, Milind; Harris, Thomas D.; Cheesman, Edward H.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001270025

PCT Pub. Number WO01/98294

Priority 60213212 21.06.00 US

Filing date 21 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 18 August 2005

International Classifications

C07D 403/00 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

18 August 2005 Application Accepted

  Published as AU-B-2001270025

15 December 2005 Standard Patent Sealed

15 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001270026

2001270024-Blends of poly(alpha-methylenelact(one)(am)) homo- and copolymers